فراهانی، محمد نقی؛ کرمی نوری، رضا؛ اوحدی، محمود (۱۳۹۰). روان شناسی، چاپ و نشر کتاب های درسی ایران سهامی خاص.
کرمی نوری، رضا. (۱۳۸۳). روان شناسی حافظه و یادگیری: با رویکردی شناختی. سازمان مطالعه و تدوین کتب علوم انسانی دانشگاه ها، تهران: انتشارات سمت.
گراث – مارنات، گری. (۱۹۹۳). راهنمای سنجش روانی ،مشاوران و روان پزشکان (دو جلد). ترجمه حسن پاشا شریفی، تهران: انتشارات رشد.
معزز، رقیه؛ پورحسین، رضا؛ بشارت، محمدعلی. (۱۳۸۹). آسیب شناسی حافظه بینایی در بیماران مبتلا به صرع .مجموعه مقالات سومین کنگره انجمن روان شناسی ایران، ۵،۷۱۴-۷۱۳٫
مستشاری، گلاره. (۱۳۸۰). ارزیابی مقدماتی درمان نگهدارنده با متادون، تهران: سازمان بهزیستی کشور، معاونت امور فرهنگی و پیشگیری.
ممتازی، سعید؛ جعفری، سارا؛ خسروی، ناصر؛نیک فرجام، علی. (۱۳۹۱). علم اعتیاد: مواد، مغز و رفتار، موسسه ملی سوء مصرف داروها، وزارت بهداشت، درمان و آموزش پزشکی، دفتر سلامت روانی، اجتمایی و اعتیاد، تهران: انتشارات سپیدبرگ.
نوربالا، احمد علی؛ باقری یزدی،کاظم محمد؛ یاسمی، محمد تقی. (۱۳۸۰). نگاهی بر سیمای سلامت روان در ایران. چاپ اول، نشر مؤلف.
نجاتی، وحید. (۱۳۹۲). ارتباط بین کارکردهای اجرایی مغز با تصمیم گیری پر خطر در دانشجویان، مجله تحقیقات علوم رفتاری، شماره۳، ص۴ .
References
Ball, J.C., Ross, A.(1991). The Effectiveness of Methadone Maintenance Treatment. New York: Springer-Verlag.195-211.
Bechara, A., Dolan, S., Denburg, N., Hindes, A.,& Anderson, SW.(2001). Nathan PE. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia .۴۵۳-۴۶۲٫
Byrd, D.A., Robinson-Papp, J., Mindt, M.R., Mintz, L., Elliott, K& et al.(2013). Isolating cognitive and neurologic HIV effects in substance-dependent confounded cohorts: a pilot study. Journal of Neuropsychol Soc ۱۹: ۴۶۳–۴۷۳٫
Czuchry, M., & Dansereau, DF. (2003). Cognitive skills training: impact on drug abuse counseling and readiness for treatment. Journal Drug Alcohol Abuse; 29(1): 1-18.
Comer, S.D., Walker, E.A., & Collins, E.D.(2005). Buprenophine/naloxone reduces the reinforcing and subjective effects of heroin in heroin dependent volunteers. Psychopharmacology (Berl), 181, 664-75.
Connock,M.,Juarez-Garcia,A.,Jowett,S.,Frew,E.,Liu,Z.,Taylor,RJ.,…& FrySmith,A.(2007). Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.Health Technology Assessment,11,9.
Comer, S.D., Walker, E.A.,& Collins, E.D.(2005).Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin dependent volunteers. Psychopharmacology (Berl) ,۱۸۱, ۶۶۴-۷۵٫
De Maeyer, J., Vanderplasschen ,W., Lammertyn, J., van Nieuwenhuizen, C., Sabbe ,B.,& Broekaert, E.(2011). Current qualityof life and its deter -minants among opiate-dependent individuals five years after starting methadone treatment. Qual Life Res, 20,139–۱۵۰٫
Darke, S., Sims, J., McDonald, S., & Wickes, W. (2000). Cognitive impairment among methadone maintenance patients. Addiction, ۹۵, ۶۸۷-۶۹۵٫
Davis, P. E., Liddiard, H., & McMillan, T. M. (2002). Neuropsychological deficits and opiate abuse. Drug and Alcohol Dependence, ۶۷,۱۰۵-۱۰۸٫
Dole – Nyswander, M., & Kreek, M.(1966). Narcotic blockade. Arch Intern Med, 118: 304-309.
Ford, C., Morton, S., Lintzeris, N., Bury, J., & Gerada. C. (2004). Guidance for the Use of Buprenorphine for the Treatment of Opioid Dependence in Primary Care. 2nd ed. London, UK: RCGP Drug and Alcohol Misuse Training Programme . (www.rcgp.org.uk/pdf/drug_buprenorphine.pdf)
Giacomuzzi, SM., Thill, C., Riemer ,Y., Garber, K., & Ertl. M. (2008). Buprenorphine-and methadone maintenance treatment: influence on aspects of cognitive and memory performance.Open Addiction journal, 1,5–۶٫
Gerra, G., Borella, F., Zaimovic, A., Moi, G., Bussandri, M., Bubici, C., & Bertacca, S.(2004). Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome. Drug Alcohol Depend, 75(1): 37–۴۵٫
Harris, DS., Mendelson, JE., Lin, ET.,Upton, RA.,& Jones, RT.(2004). Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone – Lack of dose proportionality. Clin Pharmacokinet; 43: 329-40.
Kakko, J., Svanborg, K.D., Kreek, M.J.,& Heilig, M.(2003). 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden, a randomised, placebo-controlled trial. Lancet, 361(9358): 662–۸٫
kulesza,k. (2006).Attention-Defict hyperactivity disorder and executive function: potential vulnerability for Bully/ victimization Behavior. A Doctoral Dissertation,The university of texas south western medical center at dallas.
Ling, W., Charuvastra, C., Kaim, S.C.,& Klett, C.J.(1976). Methady1 acetate and methadone as maintenance treatments for heroin addicts. a veterans administration cooperative study. Arch Gen Psychiatry , ۳۳(۶): ۷۰۹–۲۰٫
Layson-Wolf, C., Goode, J.V., & Small, R.E.(2002). Clinical use of methadone. Journal Pain Palliat Care Pharmacother ,۱۶(۱): ۲۹–۵۹٫
Lyvers, M., & Yakimoff, M.(2003). Neuropsychological correlates of opioid dependence and withdrawal. Addict Behav; 28(3): 605-11.
Mattick, R.P., Breen, C., Kimber, J.,& Davioli, M.(2004). Methadone maintenance therapy versus no opioid treplacement therapy for opioid dependence (Cochrane Review). The Cochrane Library, ۴٫ Chichester, Wiley.
McLellan, A.G., Arndt, I.O., Metzger, D.S., Woody, G.E.,& O’Brien, C.P.(1993). The effects of psychosocial services in substance abuse treatment. Journal Am Med Assoc, 269: 1953–۹٫
McNicolas, L., (2004). Clinical Guidelines for the use of Buprenorphine in the Treatment of Opioid Addiction. U.S. Department of Health and Human Services.
Novick, D.M., Joseph, H., Croxson ,T.S., et al.(1990). Absence of antibody to Human Immunodeficiency Virus in long-term, socially rehabilitated methadone maintenance patients. Archives of Internal Medicine, 150:97-99.
Petitjean, S., Stohler, R., Deglon, J.J., Livoti, S., Waldvogel, D., Uehlinger, C.,& Ladewig,D.(2001). Double-blind randomized trial of buprenorphine and methadone in opioid dependence. Drug Alcohol Depend , ۶۲(۱): ۹۷–۱۰۴٫
Pirastu, R., Fais, R., Messina, M., Bini, V., Spiga, S., Falconieri, D.,& Diana, M.(2006). Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug Alcohol Depend, 83:163–۱۶۸٫
Paulus, MP., Hozack, NE., Zauscher, BE., Frank, L., Brown, GG.,& Braff, DL.(2002). Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology; 26(1): 53-6.
Poser, S., Poser, W., Medikamente – Missbrauch & Abhängigkeit (1996). Entstehung. Verlauf. Behandlung(Pharmaceuticals and dependence: onset, course, treatment). Stuttgart, Thieme.
Robinson, T. E., & Berridge, K. C. (2003). Addiction. Annual Review of Psychology,54, 25–۵۳٫
Rapeli, P., Kivisaari, R., Autti, T., Kahkonen, S., Puuskari, V.,… & Kalska, H.(2006). Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry ۶:۹ Feb 24.
Rapeli, P., Fabritius, C., Alho, H., Salaspuro, M., Wahlbeck, K & Kalska, H.(2007).Methadone vs buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performancerelative to healthy controls. BMC Clin Pharmacol; 7: 5.
Rapeli, P., Carola Fabritius, C., Kalska, H& Alho, H.(2009). Memory function in opioid dependent patients treated with methadone or buprenorphine along with benzodiazepine:longitudinal change in comparison to healthy individuals. Substance Abuse Treatment, Prevention, and Policy. 4:6. doi:10.1186/1747-597X-4-6
Rapeli, P., Carola Fabritius, C., Kalska, H& Alho, H.(2011). Cognitive functioning in opioid dependentpatients treated with buprenorphine, methadone,and other psychoactive medications: stability and correlates. BMC Clinical Pharmacology, 11:13.
Rapeli, P., Carola Fabritius, C., Kalska, H& Alho, H.(2012).Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study. Substance Abuse Treatment, Prevention, and Policy, 7:45.
San ,L., Cami, J., Peri, J.M., Mata, R.,& Porta, M.(1990). Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial. Br Journal Addict ۸۵(۱): ۱۴۱–۷٫
Soyka, M., Banzer, K., Buchberger, R., Völkl, M.,& Naber, D.(1997). Methadone-Substitution Opiatabhängiger (Methadone substitution in opioid dependence). Nervenheilkunde, 16: 347–۵۲٫
Soyka, M., Horak, M., Dittert, S.,& Kagerer ,S.(2001). Less driving impairment on buprenorphine than methadone in drug-dependent patients? Journal Neuropsychiatry Clin Neurosci, 13:527–۵۲۸٫
Soyka, M., Hock, B., Kagerer, S., Lehnert, R., Limmer, C.,& Kuefner, H.(2005). Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine- maintained than in methadone-maintained patients. Results of a randomized clinical trial. Journal Clin Psychopharmacol, 25: 490-3.
Specka, M., Finkbeiner, T., Lodemann, E., Leifert, K., Kluwig, J., & Gastpar, M. (2000). Cognitive-motor performance of methadone-maintained patients-motor. European Addiction Research, ۶, ۸-۱۹.
Streel, E., Antoniali, V., Campanella, S.,& et al.(2005). Evaluation of cognitive functioning in 101 patients before opiate detoxification: Implications in setting up therapeutic strategies. Journal Opioid Manag; 1: 49-53.
Torrens, M., Domingo, A.S., Alonso, J., Castillo, C.,& San, L.(1999). Methadone and quality of life Lancet , 353: 1101.
Vollmer, H.C.,& Krauth, J.(2001). Therapie der Drogenabhängigkeit. In F Tretter, A Müller (eds) Psychologische Therapie der Sucht (Psychological Therapy of Addiction). Hogrefe. Göttingen, , pp. 395–۴۳۸٫